Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Asset Utilization Ratio (2016 - 2025)

Zevra Therapeutics' Asset Utilization Ratio history spans 9 years, with the latest figure at 0.38 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 201.15% year-over-year to 0.38; the TTM value through Dec 2025 reached 0.38, up 201.15%, while the annual FY2025 figure was 0.46, 241.68% up from the prior year.
  • Asset Utilization Ratio reached 0.38 in Q4 2025 per ZVRA's latest filing, up from 0.32 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.46 in Q1 2021 to a low of 18.6 in Q3 2022.
  • Average Asset Utilization Ratio over 5 years is 0.82, with a median of 0.21 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 9124.84% in 2022, then surged 201.15% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.21 in 2021, then increased by 25.78% to 0.27 in 2022, then fell by 23.1% to 0.21 in 2023, then plummeted by 37.83% to 0.13 in 2024, then soared by 201.15% to 0.38 in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Asset Utilization Ratio are 0.38 (Q4 2025), 0.32 (Q3 2025), and 0.29 (Q2 2025).